Indefinite Delivery Contract SPE2DX15D9132

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The delivery orders issued under this IDC, valued between $864 and $6,363, are for the provision of a diverse array of pharmaceutical products and medical supplies, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. These delivery orders do not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. The place of performance for these delivery orders is DMS Pharmaceutical Group's facility in Park Ridge, Illinois.